Skip to content

Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities With Blood Flow Restriction

Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities Associated With Blood Flow Restriction: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03942510
Enrollment
60
Registered
2019-05-08
Start date
2019-03-11
Completion date
2020-12-22
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise

Keywords

resistance training, vascular occlusion, hemodynamics, cardiovascular system, autonomic nervous system, heart rate, recovery of physiological function

Brief summary

Introduction: Studies on resistance training (RT) associated with blood flow restriction (BFR) have emerged as an alternative method of gaining strength and hypertrophy; however, the cardiovascular and autonomic repercussion of BFR at different intensities is unknown. Thus, it becomes relevant to investigate this type of training in post-exercise. Objective: investigate and compare autonomic and hemodynamic responses of acute eccentric RT with different intensities associated or not to BFR in healthy youngsters. Method: This is a randomized clinical trial including 60 healthy men aged 18-35 years, divided into four groups according to exercise intensity and BFR: 80% without BFR, 40% without BFR, 80% with BFR and 40% with BFR. Exercise intensity will be determined by the peak of excentric torque on the dinamometer isokinetic method and by the BFR, as being 40% of the intensity required for the complete examination of the blood flow evaluated by Doppler. Participants will do an eccentric femoral quadriceps muscle exercise session on the isokinetic dynamometer according to the previously randomized group. For recovery analyzes, the recovery heart rate (HRR) in the 1st (HRR1) and 2nd (HRR2) minute, rMSSD of 30 seconds, the hemodynamic parameters (heart rate, systolic and diastolic blood pressure, respiratory rate, peripheral oxygen saturation and rate pressure product) and heart rate variability (HRV) indices analyzed in the time domain (mean HR, rMSSD and SDNN), frequency domain (LF and HF \[nu and ms2\]) and Poincaré plot (SD1 and SD2). The analysis will be occur on baseline, immediately e after the excentric exercise and in the post exercise period for 60 minutes. Descriptive statistics method and comparison of HRV indices and hemodynamic parameters between moments and groups will be performed with the aid of the analysis of variance technique for the repetitive measures model without the schema of two sets of tests to follow . The level of significance will be p \<0.05.

Interventions

OTHEReccentric exercise with blood flow restriction

High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.

Sponsors

Paulista University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* male sex; * healthy; * aged between 18 and 35 years

Exclusion criteria

* smokers; * alcoholics; * use drugs that influenced cardiac autonomic activity; * cardiovascular, metabolic or endocrine diseases.

Design outcomes

Primary

MeasureTime frameDescription
heart rate variability indices in the time domainChange from baseline at 3rd week and 6rd weekmean HR, rMSSD and SDNN in ms
heart rate variability indices analyzed in the Poincaré plotChange from baseline at 3rd week and 6rd weekSD1 and SD2 in ms
heart rate variability indices in the frequency domainChange from baseline at 3rd week and 6rd weekLF and HF in nu and ms2
vagal reentryChange from 1 day at 10 day and 18 dayrMSSD of 30 seconds in ms
heart rate recoveryChange from 1 day at 10 day and 18 daythe recovery heart rate (HRR) in the 1st (HRR1) and 2st (HRR2) minute \[bpm\]

Secondary

MeasureTime frameDescription
hemodynamic parameterthrough study completion, an average of 6 weeksheart rate \[bpm\]

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026